Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 2004-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the safety and efficacy of brimonidine 0.1% ophthalmic solution compared with brimonidine 0.2% ophthalmic solution in patients with glaucoma or ocular hypertension

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Brimonidine Tartrate; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Ocular hypertension or glaucoma in both eyes

Exclusion Criteria:

• Uncontrolled systemic disease

• Known allergy or sensitivity to brimonidine